Monitoring antimalarial drug efficacy - Reply

Monitoring antimalarial drug efficacy - Reply

Detalhes bibliográficos
Main Authors:	Mayxay, M, Newton, P, Khanthavong, M, Tiengkham, P, Phetsouvanh, R, Phompida, S, Brockman, A, White, N
Formato:	Journal article
Publicado em:	2004

Registos relacionados

Monitoring antimalarial drug efficacy [1] (multiple letters)
Por: Ringwald, P, et al.
Publicado em: (2004)

Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.
Por: Mayxay, M, et al.
Publicado em: (2003)

Treatment response in Lao children with P-FalcimparumMalaria
Por: Mayxay, M, et al.
Publicado em: (2004)

In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos).
Por: Mayxay, M, et al.
Publicado em: (2007)

Combined molecular and clinical assessment of Plasmodium falciparum antimalarial drug resistance in the Lao People's Democratic Republic (Laos).
Por: Mayxay, M, et al.
Publicado em: (2007)

A randomized comparison of oral chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Laos.
Por: Mayxay, M, et al.
Publicado em: (2003)

Thiamin deficiency and uncomplicated falciparum malaria in Laos.
Por: Mayxay, M, et al.
Publicado em: (2007)

The assessment of antimalarial drug efficacy.
Por: White, N
Publicado em: (2002)

Diagnosis and management of malaria by rural community health providers in the Lao People's Democratic Republic (Laos).
Por: Mayxay, M, et al.
Publicado em: (2007)

SCHIZONTOCIDAL ANTIMALARIALS - A REPLY
Por: White, N, et al.
Publicado em: (1990)

Short communication: An assessment of the use of malaria rapid tests by village health volunteers in rural Laos
Por: Mayxay, M, et al.
Publicado em: (2004)

Short communication: An assessment of the use of malaria rapid tests by village health volunteers in rural Laos.
Por: Mayxay, M, et al.
Publicado em: (2004)

Counterfeit artesunate antimalarials in southeast Asia.
Por: Newton, P, et al.
Publicado em: (2003)

World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
Por: Price, R, et al.
Publicado em: (2007)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
Por: Price, R, et al.
Publicado em: (2007)

Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Por: Mayxay, M, et al.
Publicado em: (2004)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos.
Por: Mayxay, M, et al.
Publicado em: (2012)

The assessment of antimalarial drug efficacy in vivo
Por: White, NJ
Publicado em: (2022)

In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
Por: Chotivanich, K, et al.
Publicado em: (2004)

An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
Por: Mayxay, M, et al.
Publicado em: (2006)

Antimalarial drug resistance
Por: White, N
Publicado em: (2004)

Antimalarial drug resistance.
Por: White, N
Publicado em: (2004)

Cardiotoxicity of antimalarial drugs.
Por: White, N
Publicado em: (2007)

A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
Por: Mayxay, M, et al.
Publicado em: (2010)

Clinical pharmacokinetics of antimalarial drugs.
Por: White, N
Publicado em: (1985)

The threat of antimalarial drug resistance
Por: Hanboonkunupakarn, B, et al.
Publicado em: (2016)

Simplified antimalarial therapeutic monitoring: using the day-7 drug level?
Por: White, N, et al.
Publicado em: (2008)

The difference between effectiveness and efficacy of antimalarial drugs in Kenya.
Por: Amin, A, et al.
Publicado em: (2004)

Antimalarial drug resistance: the pace quickens.
Por: White, N
Publicado em: (1992)

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Por: Barnes, K, et al.
Publicado em: (2005)

Antimalarial drug quality: Methods to detect suspect drugs
Por: Kaur, H, et al.
Publicado em: (2010)

Efficacy of existing antimalarial drugs for uncomplicated malaria in Timika, Papua, Indonesia
Por: Siswantaro, H, et al.
Publicado em: (2006)

Antimalarial drug toxicity: a review.
Por: Taylor, W, et al.
Publicado em: (2004)

Mode of action and features of antimalarial drugs
Por: Nosten, F, et al.
Publicado em: (1999)

Mode of action and features of antimalarial drugs.
Por: Nosten, F, et al.
Publicado em: (1999)

Delaying antimalarial drug resistance with combination chemotherapy.
Por: White, N
Publicado em: (1999)

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
Por: White, N
Publicado em: (1997)

Preventing antimalarial drug resistance through combinations.
Por: White, N
Publicado em: (1998)

Thiamin supplementation does not reduce the frequency of adverse events after anti-malarial therapy among patients with falciparum malaria in southern Laos.
Por: Mayxay, M, et al.
Publicado em: (2014)

Antimalarial dosing regimens and drug resistance.
Por: Barnes, K, et al.
Publicado em: (2008)